[
  {
    "ts": "2025-12-08T05:32:05+00:00",
    "headline": "Jim Cramer on Merck: “The People Who Run This Company Are Not Idiots”",
    "summary": "Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer discussed, along with the tech battleground. Cramer highlighted the company’s strategic planning for when Keytruda loses patent protection. He commented: “The people who run this company are not idiots. They’ve long known that Keytruda would lose patent protection, so, for years, they’ve been […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-merck-people-run-053205748.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "d96cb170-e650-37e6-ae46-f0c63fea8a79",
      "content": {
        "id": "d96cb170-e650-37e6-ae46-f0c63fea8a79",
        "contentType": "STORY",
        "title": "Jim Cramer on Merck: “The People Who Run This Company Are Not Idiots”",
        "description": "",
        "summary": "Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer discussed, along with the tech battleground. Cramer highlighted the company’s strategic planning for when Keytruda loses patent protection. He commented: “The people who run this company are not idiots. They’ve long known that Keytruda would lose patent protection, so, for years, they’ve been […]",
        "pubDate": "2025-12-08T05:32:05Z",
        "displayTime": "2025-12-08T05:32:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/04816330227784e99fa139754a436e25",
          "originalWidth": 6244,
          "originalHeight": 4480,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/S.nF6rCTeblUWe72ybx7SA--~B/aD00NDgwO3c9NjI0NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/04816330227784e99fa139754a436e25.cf.webp",
              "width": 6244,
              "height": 4480,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qdD3WGbqTFMxaqZ_bg0aFg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/04816330227784e99fa139754a436e25.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-merck-people-run-053205748.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-merck-people-run-053205748.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-08T11:00:00+00:00",
    "headline": "Oppenheimer & Co. Inc. Strengthens Equities and Biotech Research Teams with Addition of Kostas Biliouris, Ph.D.",
    "summary": "Oppenheimer & Co. Inc., a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE: OPY), today announced that Kostas Biliouris has joined the firm as Managing Director on its Biotech Research Team. He will report to William (Bill) Bird, Director of Research, and be based in New York City.",
    "url": "https://finance.yahoo.com/news/oppenheimer-co-inc-strengthens-equities-110000398.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "a4d789af-01c9-3c08-a1bc-c0c88335373e",
      "content": {
        "id": "a4d789af-01c9-3c08-a1bc-c0c88335373e",
        "contentType": "STORY",
        "title": "Oppenheimer & Co. Inc. Strengthens Equities and Biotech Research Teams with Addition of Kostas Biliouris, Ph.D.",
        "description": "",
        "summary": "Oppenheimer & Co. Inc., a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE: OPY), today announced that Kostas Biliouris has joined the firm as Managing Director on its Biotech Research Team. He will report to William (Bill) Bird, Director of Research, and be based in New York City.",
        "pubDate": "2025-12-08T11:00:00Z",
        "displayTime": "2025-12-08T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/8de50be210153c2051f6757657dc1127",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B7xxtoJGYDrmoqAlzMVROQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/8de50be210153c2051f6757657dc1127.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7AV_8AW69YicpYLlqOr2rw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/8de50be210153c2051f6757657dc1127.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/oppenheimer-co-inc-strengthens-equities-110000398.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/oppenheimer-co-inc-strengthens-equities-110000398.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVS"
            },
            {
              "symbol": "OPY"
            },
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]